Tether 斥資 2 億美元推進腦機接口

領先的穩定幣發行商 Tether 進行了 2 億美元的策略性投資，收購了領先的腦機介面公司 Blackrock Neurotech 的多數股權。這項投資由 Tether Evo 牽頭，旨在支持 Blackrock Neurotech 突破性醫療設備的開發和商業化，重點是幫助受癱瘓和神經系統疾病影響的個人。

Tether Invests $200 Million in Blackrock Neurotech to Advance Brain-Computer Interface Technologies

Tether 向 Blackrock Neurotech 投資 2 億美元，以推進腦機介面技術

Tether, the issuer of the leading stablecoin USDT, has announced a substantial investment of $200 million to acquire a majority stake in Blackrock Neurotech, a pioneering company specializing in brain-computer interface (BCI) technology.

領先的穩定幣 USDT 發行人 Tether 宣布斥資 2 億美元收購 Blackrock Neurotech 的多數股權，Blackrock Neurotech 是一家專注於腦機介面（BCI）技術的先驅公司。

This strategic investment, made through Tether's venture capital arm, Tether Evo, reflects the company's commitment to supporting the development and commercialization of Blackrock Neurotech's innovative medical devices.

這項策略性投資是透過 Tether 的創投部門 Tether Evo 進行的，反映了該公司對支持 Blackrock Neurotech 創新醫療設備的開發和商業化的承諾。

Blackrock Neurotech is renowned for its expertise in creating medical devices that utilize brain signals, offering hope to individuals affected by paralysis and other neurological disorders. It is important to note that Blackrock Neurotech is distinct from the asset management giant BlackRock.

Blackrock Neurotech 以其在製造利用大腦訊號的醫療設備方面的專業知識而聞名，為遭受癱瘓和其他神經系統疾病影響的個人帶來了希望。值得注意的是，Blackrock Neurotech 與資產管理巨頭 BlackRock 不同。

The capital infusion from Tether will enable Blackrock Neurotech to expand its operations, including the deployment and market entry of its groundbreaking medical devices. The funds will also support ongoing research and development initiatives to further enhance the company's technology portfolio.

Tether 的注資將使 Blackrock Neurotech 能夠擴大其業務，包括其突破性醫療設備的部署和市場進入。這些資金還將支持正在進行的研究和開發計劃，以進一步增強公司的技術組合。

With a market capitalization of $110 billion, Tether dominates the stablecoin market. In recent years, the company has expanded its interests by establishing four distinct business units beyond stablecoin issuance.

Tether 市值 1100 億美元，在穩定幣市場佔據主導地位。近年來，該公司透過在穩定幣發行之外建立四個不同的業務部門來擴大其業務範圍。

Paolo Ardoino, CEO of Tether, stated the company's unwavering commitment to investing in emerging technologies with the potential to transform society. He expressed particular enthusiasm for Blackrock Neurotech's BCI technology, highlighting its ability to revolutionize communication, rehabilitation, and cognitive enhancement.

Tether 執行長 Paolo Ardoino 表示，該公司堅定不移地致力於投資具有改變社會潛力的新興技術。他對 Blackrock Neurotech 的 BCI 技術表達了特別的熱情，強調了其徹底改變溝通、復原和認知增強的能力。

"We are excited to partner with Blackrock Neurotech and support their mission of developing life-changing medical devices," Ardoino said. "We believe that their BCI technology has the potential to unlock new possibilities for individuals living with neurological challenges."

Ardoino 表示：“我們很高興與 Blackrock Neurotech 合作，支持他們開發改變生活的醫療設備的使命。” “我們相信他們的腦機介面技術有潛力為患有神經系統疾病的個體帶來新的可能性。”

Blackrock Neurotech's technology leverages cutting-edge neural interfaces to bridge the gap between the brain and external devices. By translating brain signals into commands, BCI systems enable individuals with limited mobility or speech difficulties to communicate, control computers, and even operate robotic limbs.

Blackrock Neurotech 的技術利用尖端的神經介面來彌合大腦和外部設備之間的差距。透過將大腦訊號轉化為命令，腦機介面系統使行動不便或言語困難的個人能夠進行溝通、控制計算機，甚至操作機器人肢體。

The investment in Blackrock Neurotech aligns with Tether's broader commitment to fostering technological innovation and supporting companies that are addressing real-world challenges. Tether Evo serves as a catalyst for the company's diversification efforts, enabling it to invest in promising ventures that have the potential to drive growth and make a positive impact on society.

對 Blackrock Neurotech 的投資符合 Tether 對促進技術創新和支持應對現實世界挑戰的公司的更廣泛承諾。 Tether Evo 是該公司多元化努力的催化劑，使其能夠投資於有潛力推動成長並對社會產生積極影響的有前途的企業。